Flourish Research’s Post

First to enroll is more than a milestone. It is a signal of site readiness. In a recent nationwide early phase #RSV #vaccine study with a narrow enrollment window, Flourish Research was the first across all participating sites to enroll. Through rigorous preparation for a complex #recombinant #vaccine trial, combined with targeted community outreach and a robust patient database, Flourish Research had qualified participants ready for rapid screening within the sponsor’s strict recruitment window. Congratulations to Manish Jain, MD and our Chicago Ravenswood team on this achievement! 💡 Learn more about our vaccine trial capabilities or connect with our team: https://lnkd.in/gDY2H3VH #Vaccines #ClinicalTrials #ClinicalResearch